Article

Genenta Science SpA announced a strategic shift to focus on the defense sector, changing its name to Saentra Forge S.p.A. The company plans to acquire profitable Italian businesses in national security, targeting EBITDA of up to €5 million.

Genenta has agreed to fund ATC, a tactical rifle manufacturer, aiming to acquire a controlling stake based on performance milestones. ATC projects revenues of €4.0 million in 2026, rising to €9.0 million in 2027, with EBITDA expected to double by 2027.

The Praexidia Foundation has become a strategic shareholder. Genenta will maintain its biotech platform through partnerships and expects $33 million in cash equivalents by December 31, 2025.